Cardio-TriTest vs Autoplaque

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Cardio-TriTest

by Cardio-Phoenix

Autoplaque

by APQ Health (formerly Cedars-Sinai Medical Center: AIM)

AI Verdict

Cardio-TriTest is a device-based solution for real-time, multi-modal bio-signal acquisition (ECG, PCG, MCG) to detect cardiovascular disease in primary care. In contrast, Autoplaque is workstation-based software that analyzes CT angiography images for quantitative assessment of coronary plaques and luminal stenoses. While both tools contribute to cardiovascular health assessment, they address different stages and types of data in the diagnostic pathway, making them complementary rather than direct competitors.

Choose Cardio-TriTest if…

Choose Cardio-TriTest if your primary care clinic requires a comprehensive, non-invasive, and early diagnostic tool for cardiovascular disease. This device is ideal for synchronizing and visually correlating multiple heart bio-signals (ECG, PCG, MCG) to provide a broad initial assessment and aid in earlier detection of potential issues.

View Cardio-TriTest →

Choose Autoplaque if…

Choose Autoplaque if your cardiology or radiology department needs advanced AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. This tool is best suited for detailed risk stratification and guiding treatment decisions based on precise measurements of atherosclerotic plaque and stenosis burden.

View Autoplaque →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Cardio-TriTest	Autoplaque
Deployment	On-premise (device)	Workstation-based post-processing application, runs on Windows or Mac OS.
FDA Status	Unknown	Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cardio-TriTest

Cardio-TriTest is designed for primary care, offering a non-invasive test procedure that integrates into existing ECG workflows and can be operated by nurses or HCAs, simplifying interpretation for general practitioners. In contrast, Autoplaque is workstation-based software, which, while interactive, may imply a less integrated workflow compared to solutions designed for broader clinical use.

Clinical Value

Autoplaque

Autoplaque provides FDA-cleared, AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography, aiding in heart attack risk prediction and treatment guidance with detailed biometric information. Cardio-TriTest offers earlier and more comprehensive cardiovascular disease detection in primary care by combining three bio-signals, identifying 'Echo Diseases' often missed by standard ECGs. However, Autoplaque's precise quantitative analysis from advanced imaging offers more definitive and actionable insights for specialized patient management.

Pricing & Value

Tie

Both Cardio-TriTest and Autoplaque lack transparent public pricing information, with both stating 'contact for pricing' or 'not disclosed.' This absence of specific pricing details makes it impossible to conduct a meaningful head-to-head comparison of their cost-effectiveness or overall value proposition.

Enterprise Readiness

Cardio-TriTest

Cardio-TriTest explicitly states it is HIPAA compliant and mentions EMR import paths, which are crucial for enterprise adoption. Autoplaque, while a workstation-based software handling DICOM data, does not explicitly specify HIPAA compliance or the availability of a Business Associate Agreement (BAA) in the provided information or search results, posing a potential barrier for large-scale enterprise deployment.

Innovation

Cardio-TriTest

Cardio-TriTest demonstrates significant innovation through its AI-powered 3-in-1 diagnostic device, combining and synchronizing ECG, PCG, and MCG bio-signals for visual correlation and earlier, more comprehensive cardiovascular disease detection in primary care. This multi-modal data fusion for primary care screening represents a novel approach to diagnostics. Autoplaque's quantitative analysis of coronary plaques from CT angiography is also innovative, but Cardio-TriTest's integrated bio-signal approach for broad screening stands out.

Support & Docs

Tie

Neither tool provides substantial public details regarding their customer support infrastructure or comprehensive documentation. Cardio-Phoenix Inc. has limited publicly available information for Cardio-TriTest beyond a general contact email, and while Autoplaque's user manual is referenced in FDA filings, no further public details on dedicated support or documentation are available.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Cardio-TriTest	Autoplaque
Name	Cardio-TriTest	Autoplaque
Company	Cardio-Phoenix Inc.	Cedars-Sinai Medical Center: AIM
Primary Function	AI-powered 3-in-1 diagnostic device combining ECG, PCG, and MCG to synchronize and visually correlate heart bio-signals for earlier and more comprehensive cardiovascular disease detection in primary care.	AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance.
Key Diagnostic Modalities/Input	ECG, PCG, MCG (bio-signals)	CT angiography images
Key Output/Analysis	Synchronized and visual correlation of heart bio-signals, AI-powered analysis for heart disease detection	Quantitative analysis of atherosclerotic plaque, detection and characterization of coronary artery plaque, measurement of luminal stenoses, analysis of coronary anatomy and pathology
Categories	Cardiology AI	Cardiology AI, Radiology & Imaging AI
Specialties	Cardiology, Family Medicine, Internal Medicine	Cardiology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Cardio-TriTest and Autoplaque.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows for cardiovascular assessment?

Cardio-TriTest is a device-based solution designed for non-invasive, 3-in-1 diagnostic testing directly in a clinical setting, suitable for primary care for earlier and more comprehensive cardiovascular disease detection. Autoplaque is workstation-based software that performs post-processing analysis of existing CT angiography images to quantify coronary plaques and stenoses, aiding in heart attack risk prediction and treatment guidance.

Which clinical specialties are these tools primarily designed to support, and what specific clinical problems do they address?

Cardio-TriTest supports Cardiology, Family Medicine, and Internal Medicine, focusing on earlier and more comprehensive cardiovascular disease detection through synchronized bio-signal acquisition. Autoplaque is for Cardiology and Radiology, aiding in heart attack risk prediction and treatment guidance by providing quantitative analysis of coronary plaques and luminal stenoses from CT angiography images.

What specific diagnostic capabilities do these tools offer for cardiovascular disease detection and risk assessment?

Cardio-TriTest provides synchronized acquisition and visual correlation of ECG, PCG, and MCG bio-signals for comprehensive heart disease detection, including identifying events in the cardiac cycle and detecting heart sounds and murmurs. Autoplaque offers AI-powered quantitative analysis to detect, characterize, and measure coronary artery plaque and luminal stenoses from CT angiography images, providing biometric information such as calcified and non-calcified plaque volume and stenosis percentage.

What is the expected user interaction and potential learning curve for physicians to effectively utilize each tool?

Cardio-TriTest involves operating a 3-in-1 diagnostic device to acquire and interpret synchronized bio-signal outputs, with visual correlation designed to simplify interpretation for general practitioners. Autoplaque is a workstation-based software where clinicians review and can edit automated vessel, plaque, and lumen segmentations, and utilize multiplanar reformatting views for analysis.

Do these tools provide features for clinicians to review, modify, or audit the AI's analysis?

Autoplaque specifically highlights automated vessel, plaque, and lumen segmentation that is reviewable and editable by the clinician, implying a level of control over the AI's output. The provided information for Cardio-TriTest does not detail specific audit or modification features for its AI analysis.

What are the key considerations for deploying these tools across multiple clinical sites or workstations?

Deploying Cardio-TriTest would involve the physical installation and setup of a device in each clinical setting. Autoplaque, being workstation-based software, would require installation on Windows or Mac computer platforms at each desired workstation or site.